Abstract
Clostridium difficile infection (CDI) is a well-known complication of antibiotic therapy. It is associated with significant morbidity, mortality, and cost in the hospital setting. The main symptoms include watery diarrhea, abdominal pain, and distension, but CDI can also present as toxic megacolon, bowel perforation with peritonitis, sepsis and renal failure. Therapy includes metronidazole and oral vancomycin, with rectal vancomycin and fecal transplant reserved for more complicated cases. Adjunctive treatments such as probiotics have been tried with mixed results. We present a patient with complicated CDI treated with adjuvant serum-derived bovine immunoglobulin, a novel approach in this context.
References
Nov 23, 2006·Annals of Internal Medicine·John G Bartlett
Mar 24, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stuart H CohenUNKNOWN Infectious Diseases Society of America
Jun 7, 2014·Clinical and Experimental Gastroenterology·Bryon W PetschowGerald L Klein
Sep 11, 2014·World Journal of Gastroenterology : WJG·Bryon W PetschowJ Marc Rhoads
Jan 28, 2015·JAMA : the Journal of the American Medical Association·Natasha BagdasarianPreeti N Malani
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
Mar 26, 2015·World Journal of Gastroenterology : WJG·Larry GoodRaymond Panas
Apr 2, 2015·PloS One·Christopher J DetzelEric M Weaver
Jun 18, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Emma BatemanDorothy Keefe
Nov 12, 2015·Therapeutic Advances in Gastroenterology·Ira ShafranBruce P Burnett
May 4, 2016·PloS One·Anna Pérez-BosqueMiquel Moretó
Dec 17, 2016·Clinical and Experimental Gastroenterology·Audrey L ShawTimothy P Bradshaw
Jan 26, 2017·The New England Journal of Medicine·Mark H WilcoxUNKNOWN MODIFY I and MODIFY II Investigators